Budiarto, Bugi Ratno
Azamris,
Desriani,
Funding for this research was provided by:
Unggulan Lipi 2015
Article History
Received: 15 April 2017
Accepted: 14 August 2017
First Online: 5 October 2017
Competing interest
: The authors declare that they have no competing interest.
: This study is a part of the big research entitled “<i>Studi keragaman gen HER2/neu pada Pasien Kanker Payudara di Indonesia</i>: <i>Strategi Mendapatkan Obat yang Tepat Sasaran Mengatasi Permasalahan Resistensi dan Toksisitas Trastuzumab</i>” in which all subjects enrolled in this experiment were approved by the local ethics committee, issued by the Ministry of Health, Republic of Indonesia.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.